Literature DB >> 18603534

Embryonic motor axon development in the severe SMA mouse.

Vicki L McGovern1, Tatiana O Gavrilina, Christine E Beattie, Arthur H M Burghes.   

Abstract

Spinal muscular atrophy (SMA) is caused by reduced levels of survival motor neuron (SMN) protein. Previously, cultured SMA motor neurons showed reduced growth cone size and axonal length. Furthermore, reduction of SMN in zebrafish resulted in truncation followed by branching of motor neuron axons. In this study, motor neurons labeled with green fluorescent protein (GFP) were examined in SMA mice from embryonic day 10.5 to postnatal day 2. SMA motor axons showed no defect in axonal formation or outgrowth at any stage of development. However, a significant increase in synapses lacking motor axon input was detected in embryonic SMA mice. Therefore, one of the earliest detectable morphological defects in the SMA mice is the loss of synapse occupation by motor axons. This indicates that in severe SMA mice there are no defects in motor axon formation however, we find evidence of denervation in embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603534      PMCID: PMC2722893          DOI: 10.1093/hmg/ddn189

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  59 in total

1.  Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7.

Authors:  C F Rochette; L C Surh; P N Ray; P E McAndrew; T W Prior; A H Burghes; M Vanasse; L R Simard
Journal:  Neurogenetics       Date:  1997-09       Impact factor: 2.660

2.  The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells.

Authors:  P J Young; T T Le; N thi Man; A H Burghes; G E Morris
Journal:  Exp Cell Res       Date:  2000-05-01       Impact factor: 3.905

3.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

Authors:  U R Monani; M Sendtner; D D Coovert; D W Parsons; C Andreassi; T T Le; S Jablonka; B Schrank; W Rossoll; W Rossol; T W Prior; G E Morris; A H Burghes
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

4.  Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy.

Authors:  T Frugier; F D Tiziano; C Cifuentes-Diaz; P Miniou; N Roblot; A Dierich; M Le Meur; J Melki
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

5.  A mouse model for spinal muscular atrophy.

Authors:  H M Hsieh-Li; J G Chang; Y J Jong; M H Wu; N M Wang; C H Tsai; H Li
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  Identification of a novel missense mutation of the SMN(T) gene in two siblings with spinal muscular atrophy.

Authors:  C H Wang; B D Papendick; P Bruinsma; J K Day
Journal:  Neurogenetics       Date:  1998-08       Impact factor: 2.660

7.  A novel nuclear structure containing the survival of motor neurons protein.

Authors:  Q Liu; G Dreyfuss
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

8.  Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord.

Authors:  S Pagliardini; A Giavazzi; V Setola; C Lizier; M Di Luca; S DeBiasi; G Battaglia
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

9.  An internet-accessible database of mouse developmental anatomy based on a systematic nomenclature.

Authors:  J L Bard; M H Kaufman; C Dubreuil; R M Brune; A Burger; R A Baldock; D R Davidson
Journal:  Mech Dev       Date:  1998-06       Impact factor: 1.882

10.  Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy.

Authors:  C Cifuentes-Diaz; T Frugier; F D Tiziano; E Lacène; N Roblot; V Joshi; M H Moreau; J Melki
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

View more
  75 in total

1.  Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.

Authors:  Rocky G Gogliotti; Katharina A Quinlan; Courtenay B Barlow; Christopher R Heier; C J Heckman; Christine J Didonato
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

Review 2.  Spinal muscular atrophy: new and emerging insights from model mice.

Authors:  Gyu-Hwan Park; Shingo Kariya; Umrao R Monani
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

Review 3.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

4.  Alpha-synuclein loss in spinal muscular atrophy.

Authors:  Gyula Acsadi; Xingli Li; Kelley J Murphy; Kathryn J Swoboda; Graham C Parker
Journal:  J Mol Neurosci       Date:  2010-07-17       Impact factor: 3.444

5.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

6.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

7.  Temporal requirement for SMN in motoneuron development.

Authors:  Le T Hao; Phan Q Duy; James D Jontes; Marc Wolman; Michael Granato; Christine E Beattie
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

8.  Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Authors:  Suzan M Hammond; Gareth Hazell; Fazel Shabanpoor; Amer F Saleh; Melissa Bowerman; James N Sleigh; Katharina E Meijboom; Haiyan Zhou; Francesco Muntoni; Kevin Talbot; Michael J Gait; Matthew J A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

9.  Reduced levels of survival motor neuron protein leads to aberrant motoneuron growth in a Xenopus model of muscular atrophy.

Authors:  Qods Ymlahi-Ouazzani; Odile J Bronchain; Elodie Paillard; Chantal Ballagny; Albert Chesneau; Aurélie Jadaud; André Mazabraud; Nicolas Pollet
Journal:  Neurogenetics       Date:  2009-06-11       Impact factor: 2.660

10.  SMN-targeted therapeutics for spinal muscular atrophy: are we SMArt enough yet?

Authors:  Kathryn J Swoboda
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.